Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 10;63(9):e0149222.
doi: 10.1128/jcm.01492-22. Epub 2025 Aug 20.

Type-specific EV-D68 real-time RT-PCR assay for the detection of all extant enterovirus D68 strains

Affiliations

Type-specific EV-D68 real-time RT-PCR assay for the detection of all extant enterovirus D68 strains

Terry Fei Fan Ng et al. J Clin Microbiol. .

Abstract

We developed a type-specific Enterovirus D68 (EV-D68) real-time RT-PCR (rRT-PCR) assay termed CDC2022, which targets sequences encoding conserved amino acid regions of all extant EV-D68 strains. We targeted three motifs conserved among all strains in the last 60 years. The assay achieved 100% (281/281) sensitivity and 100% (344/344) specificity when tested with a collection of 625 respiratory specimens, compared to the gold-standard EV semi-nested VP1 PCR and sequencing assay (snPCR/Seq). CDC2022 gave negative results with 289/289 non-target viruses, including 104 EV A-D isolates, 165 rhinovirus (RV) isolates or clinical specimens, and 14 other common respiratory viruses. The limit of detection (LOD) of the CDC2022 assay is 361 copies per reaction, as determined using serially diluted RNA transcripts. It can detect as few as 0.28 CCID50 per reaction with titrated isolates. An in silico "phylo-primer-mismatch" analysis was performed to visualize primer/probe mismatches and to compare CDC2022 with other EV-D68 rRT-PCR assays. It showed that CDC2022 has the fewest primer/probe mismatches among all assays analyzed and is suitable for all clades. As a type-specific assay targeting conserved amino acids, the CDC2022 assay allowed detection of newer strains from 2024. The CDC 2022 assay could provide a critical tool for molecular surveillance of EV-D68.IMPORTANCEEV-D68 has caused recurring respiratory disease outbreaks in the United States since 2014. As recurrent outbreaks and continued virus evolution are expected for EV-D68, the CDC2022 rRT-PCR provides a robust test that detects known strains as well as potential emerging strains. This type-specific assay approach is critical for national EV-D68 surveillance and clinical diagnostics. An in silico "phylo-primer-mismatch" approach is invented to show EV-D68 assay robustness, but it has utility in new molecular tests for pathogen detection.

Keywords: EV-D68; Enterovirus D68; diagnostic assay; rRT-PCR; real-time PCR.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
Conserved motifs targeted for CDC2022 pan-EV-D68 rRT-PCR.
Fig 2
Fig 2
Phlyo-primer-mismatch graph for visualization of primer/probe mismatches against the EV-D68 phylogeny. Alignment of 359 representative deduplicated VP1 nucleotides was used to construct a neighbor-joining tree. Primer/probe mismatches to each sequence were tabulated and overlaid with the tree. Sense primer, antisense primer, and probe were evaluated in this order for each assay. WU and NU assays have two antisense primers. S, sense primer; A, antisense primer; A1, antisense-1 primer; A2, antisense-2 primer; P, probe. Blue, 0 mismatches; yellow, one mismatch; orange, two mismatches; red, three or more mismatches.
Fig 3
Fig 3
Clinical sensitivity of CDC-2022 rRT-PCR compared against the gold-standard snPCR/Seq. (A) Breakdown of the EV-D68-positive specimens tested by snPCR/Seq. (B) Breakdown of all other specimens tested and their snPCR/Seq result. (C) Confusion matrix of the rRT-PCR compared to snPCR/Seq showing the assay’s sensitivity and specificity in clinical specimens described in (A and B).

References

    1. Schieble JH, Fox VL, Lennette EH. 1967. A probable new human picornavirus associated with respiratory diseases. Am J Epidemiol 85:297–310. doi: 10.1093/oxfordjournals.aje.a120693 - DOI - PubMed
    1. Kidd S, Lopez AS, Konopka-Anstadt JL, Nix WA, Routh JA, Oberste MS. 2020. Enterovirus D68-associated acute flaccid myelitis, United States, 2020. Emerg Infect Dis 26. doi: 10.3201/eid2610.201630 - DOI - PMC - PubMed
    1. Mishra N, Ng TFF, Marine RL, Jain K, Ng J, Thakkar R, Caciula A, Price A, Garcia JA, Burns JC, Thakur KT, Hetzler KL, Routh JA, Konopka-Anstadt JL, Nix WA, Tokarz R, Briese T, Oberste MS, Lipkin WI. 2019. Antibodies to enteroviruses in cerebrospinal fluid of patients with acute flaccid myelitis. mBio 10:e01903-19. doi: 10.1128/mBio.01903-19 - DOI - PMC - PubMed
    1. Schubert RD, Hawes IA, Ramachandran PS, Ramesh A, Crawford ED, Pak JE, Wu W, Cheung CK, O’Donovan BD, Tato CM, et al. 2019. Pan-viral serology implicates enteroviruses in acute flaccid myelitis. Nat Med 25:1748–1752. doi: 10.1038/s41591-019-0613-1 - DOI - PMC - PubMed
    1. Vogt MR, Wright PF, Hickey WF, De Buysscher T, Boyd KL, Crowe JE Jr. 2022. Enterovirus D68 in the anterior horn cells of a child with acute flaccid myelitis. N Engl J Med 386:2059–2060. doi: 10.1056/NEJMc2118155 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources